To analyze if CSF CD20+ T cells from healthy individuals had a proinflammatory phenotype, as previously described for CD20+ T cells from patients with RRMS (21), we measured the surface expression of CXCR3 and CCR6 (Figure 1E). This evidence concerns the gene CSF2 and relapsing-remitting multiple sclerosis.